280 related articles for article (PubMed ID: 29367697)
1. Identification of microRNA signature in the progression of gestational trophoblastic disease.
Zhao JR; Cheng WW; Wang YX; Cai M; Wu WB; Zhang HJ
Cell Death Dis; 2018 Jan; 9(2):94. PubMed ID: 29367697
[TBL] [Abstract][Full Text] [Related]
2. Distinct microRNA profiles for complete hydatidiform moles at risk of malignant progression.
Lin LH; Maestá I; St Laurent JD; Hasselblatt KT; Horowitz NS; Goldstein DP; Quade BJ; Sun SY; Braga A; Fisher RA; Berkowitz RS; Elias KM
Am J Obstet Gynecol; 2021 Apr; 224(4):372.e1-372.e30. PubMed ID: 33031755
[TBL] [Abstract][Full Text] [Related]
3. miR-21 Is Overexpressed in Hydatidiform Mole Tissues and Promotes Proliferation, Migration, and Invasion in Choriocarcinoma Cells.
Wang YX; Zhao JR; Xu YY; Wu WB; Zhang HJ
Int J Gynecol Cancer; 2017 Feb; 27(2):364-374. PubMed ID: 27922982
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA Expression Profiling in Hydatidiform Mole for the Prediction of Postmolar GTN : MicroRNA Profile in Postmolar GTN.
Teerapakpinyo C; Areeruk W; Tantbirojn P; Phupong V; Shuangshoti S; Lertkhachonsuk R
Technol Cancer Res Treat; 2022; 21():15330338211067309. PubMed ID: 35023789
[No Abstract] [Full Text] [Related]
5. The microRNA expression signature of small cell lung cancer: tumor suppressors of miR-27a-5p and miR-34b-3p and their targeted oncogenes.
Mizuno K; Mataki H; Arai T; Okato A; Kamikawaji K; Kumamoto T; Hiraki T; Hatanaka K; Inoue H; Seki N
J Hum Genet; 2017 Jul; 62(7):671-678. PubMed ID: 28275243
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of PDCD4 by deSUMOylation associates with the progression of gestational trophoblastic disease.
Wang YX; Cui L; Wu WB; Quinn MJ; Menon R; Zhao JR; Zhang HJ
Placenta; 2022 Dec; 130():17-24. PubMed ID: 36370491
[TBL] [Abstract][Full Text] [Related]
7. Loss of Selenoprotein Iodothyronine Deiodinase 3 Expression Correlates with Progression of Complete Hydatidiform Mole to Gestational Trophoblastic Neoplasia.
St Laurent JD; Lin LH; Owen DM; Maestá I; Castaneda A; Hasselblatt KT; Goldstein DP; Horowitz NS; Berkowitz RS; Elias KM
Reprod Sci; 2021 Nov; 28(11):3200-3211. PubMed ID: 34129219
[TBL] [Abstract][Full Text] [Related]
8. RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
Toda H; Seki N; Kurozumi S; Shinden Y; Yamada Y; Nohata N; Moriya S; Idichi T; Maemura K; Fujii T; Horiguchi J; Kijima Y; Natsugoe S
Mol Oncol; 2020 Feb; 14(2):426-446. PubMed ID: 31755218
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA profiling in complete and partial hydatidiform moles.
Chia WK; Yeoh HXY; Mustangin M; Khong TY; Wong YP; Tan GC
Malays J Pathol; 2023 Dec; 45(3):353-362. PubMed ID: 38155377
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs.
He H; Wang L; Zhou W; Zhang Z; Wang L; Xu S; Wang D; Dong J; Tang C; Tang H; Yi X; Ge J
PLoS One; 2015; 10(5):e0125672. PubMed ID: 25938468
[TBL] [Abstract][Full Text] [Related]
11. Deregulated MicroRNAs in Cancer-Associated Fibroblasts from Front Tumor Tissues of Lung Adenocarcinoma as Potential Predictors of Tumor Promotion.
Negrete-Garcia MC; Ramírez-Rodriguez SL; Rangel-Escareño C; Muñoz-Montero S; Kelly-García J; Vázquez-Manríquez ME; Santillán P; Ramírez MM; Ramírez-Martínez G; Ramírez-Venegas A; Ortiz-Quintero B
Tohoku J Exp Med; 2018 Oct; 246(2):107-120. PubMed ID: 30369556
[TBL] [Abstract][Full Text] [Related]
12. miR-615-3p promotes proliferation and migration and inhibits apoptosis through its potential target CELF2 in gastric cancer.
Wang J; Liu L; Sun Y; Xue Y; Qu J; Pan S; Li H; Qu H; Wang J; Zhang J
Biomed Pharmacother; 2018 May; 101():406-413. PubMed ID: 29501762
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome.
Siu MK; Wong ES; Chan HY; Ngan HY; Chan KY; Cheung AN
Am J Pathol; 2008 Oct; 173(4):1165-72. PubMed ID: 18772339
[TBL] [Abstract][Full Text] [Related]
14. Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma.
Mataki H; Seki N; Mizuno K; Nohata N; Kamikawaji K; Kumamoto T; Koshizuka K; Goto Y; Inoue H
Oncotarget; 2016 Nov; 7(44):72084-72098. PubMed ID: 27765924
[TBL] [Abstract][Full Text] [Related]
15. Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.
Sugawara S; Yamada Y; Arai T; Okato A; Idichi T; Kato M; Koshizuka K; Ichikawa T; Seki N
J Hum Genet; 2018 May; 63(5):657-668. PubMed ID: 29540855
[TBL] [Abstract][Full Text] [Related]
16. FBI-1 Is Overexpressed in Gestational Trophoblastic Disease and Promotes Tumor Growth and Cell Aggressiveness of Choriocarcinoma via PI3K/Akt Signaling.
Mak VC; Wong OG; Siu MK; Wong ES; Ng WY; Wong RW; Chan KK; Ngan HY; Cheung AN
Am J Pathol; 2015 Jul; 185(7):2038-48. PubMed ID: 26093985
[TBL] [Abstract][Full Text] [Related]
17. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
[TBL] [Abstract][Full Text] [Related]
18. microRNA-128-3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down-regulating NEK2.
Chen Y; Wu N; Liu L; Dong H; Liu X
J Cell Mol Med; 2020 Jul; 24(13):7353-7369. PubMed ID: 32558224
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
